{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:32:28Z","timestamp":1790566348942,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.suc.2024.04.009","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:36:41Z","timestamp":1715859401000},"page":"1065-1081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Surgery in \u201cOligometastatic\u201d Pancreas Cancer"],"prefix":"10.1016","volume":"104","author":[{"given":"D. Brock","family":"Hewitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.suc.2024.04.009_bib2","first-page":"278","article-title":"Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence","volume":"100","author":"Hughes","year":"1986","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases","volume":"113","author":"Pastorino","year":"1997","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.suc.2024.04.009_bib4","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1245\/s10434-007-9520-7","article-title":"Laparoscopic adrenalectomy for isolated adrenal metastasis","volume":"14","author":"Strong","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.suc.2024.04.009_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/cncr.29134","article-title":"The rise in metastasectomy across cancer types over the past decade","volume":"121","author":"Bartlett","year":"2015","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib6","doi-asserted-by":"crossref","first-page":"102067","DOI":"10.1016\/j.esmoop.2023.102067","article-title":"Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus","volume":"8","author":"Leonhardt","year":"2023","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.suc.2024.04.009_bib7","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4240\/wjgs.v15.i7.1512","article-title":"Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review","volume":"15","author":"Halle-Smith","year":"2023","journal-title":"World J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.suc.2024.04.009_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ags3.12655","article-title":"Essential updates 2021\/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma","volume":"7","author":"Yasuda","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"issue":"12","key":"10.1016\/j.suc.2024.04.009_bib9","doi-asserted-by":"crossref","first-page":"e033452","DOI":"10.1136\/bmjopen-2019-033452","article-title":"Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1)","volume":"9","author":"Wei","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1186\/s12885-021-08966-3","volume":"21","author":"Gebauer","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13063-022-06049-7","article-title":"Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)","volume":"23","author":"Yamamoto","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.suc.2024.04.009_bib12","author":"Ghadimi"},{"key":"10.1016\/j.suc.2024.04.009_bib13","unstructured":"Bj\u00f6rnsson B., Surgery for Liver Metastases from PDAC (ScanPan1). NCT05271110."},{"key":"10.1016\/j.suc.2024.04.009_bib14","unstructured":"Thiels C., Phase II Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis. 2021. NCT04858009."},{"key":"10.1016\/j.suc.2024.04.009_bib15","unstructured":"Zani S., Hepatic Resection for Metastatic Pancreas Cancer. 2018. NCT02892305."},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(20)30074-7","article-title":"Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial","volume":"21","author":"Pishvaian","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2024.04.009_bib18","unstructured":"SEER\u2217Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2024. Available at: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Data source(s): SEER Incidence Data, November 2023 Submission (1975-2021), SEER 22 registries. Accessed May 8, 2024."},{"issue":"11","key":"10.1016\/j.suc.2024.04.009_bib19","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2022.3829","article-title":"Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial","volume":"8","author":"Conroy","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.suc.2024.04.009_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000004155","article-title":"Surgical outcome results from SWOG S1505: a randomized clinical trial of mFOLFIRINOX versus gemcitabine\/nab-paclitaxel for perioperative treatment of resectable pancreatic ductal adenocarcinoma","author":"Ahmad","year":"2020","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.04.009_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","article-title":"Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial","volume":"8","author":"Ghaneh","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.suc.2024.04.009_bib22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.suc.2024.04.009_bib23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.suc.2024.04.009_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020525","article-title":"Real World data for pancreatic adenocarcinoma from a population-based study in France","volume":"15","author":"Badic","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.suc.2024.04.009_bib25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/MPA.0000000000001133","article-title":"Long-term survivors of pancreatic cancer: a california population-based study","volume":"47","author":"Kardosh","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.suc.2024.04.009_bib26","series-title":"Cancer facts & figures 2024","author":"Society","year":"2024"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib27","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline","volume":"381","author":"Golan","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"34","key":"10.1016\/j.suc.2024.04.009_bib29","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.21.01604","article-title":"Overall survival results from the POLO trial: a phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer","volume":"40","author":"Kindler","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.suc.2024.04.009_bib30","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.18632\/oncotarget.25036","article-title":"Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years","volume":"9","author":"Hall","year":"2018","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.suc.2024.04.009_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184464","article-title":"Changing practice patterns and improving survival for patients with pancreatic ductal adenocarcinoma","volume":"15","author":"Underwood","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib32","doi-asserted-by":"crossref","first-page":"102944","DOI":"10.1016\/j.esmoop.2024.102944","article-title":"Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group","volume":"9","author":"Weiss","year":"2024","journal-title":"ESMO Open"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000184739","article-title":"Resection of primary pancreatic cancer and liver metastasis: a systematic review","volume":"25","author":"Michalski","year":"2008","journal-title":"Dig Surg"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib34","first-page":"366","article-title":"[Is liver resection in metastases of exocrine pancreatic carcinoma justified?]","volume":"67","author":"Klempnauer","year":"1996","journal-title":"Chirurg"},{"issue":"3\u20134","key":"10.1016\/j.suc.2024.04.009_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000313532","article-title":"Treatment of metachronous and simultaneous liver metastases of pancreatic cancer","volume":"44","author":"D\u00fcnschede","year":"2010","journal-title":"Eur Surg Res"},{"issue":"11","key":"10.1016\/j.suc.2024.04.009_bib36","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/cncr.23074","article-title":"Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?","volume":"110","author":"Gleisner","year":"2007","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.sla.0000245845.06772.7d","article-title":"Surgery for recurrent pancreatic ductal adenocarcinoma","volume":"245","author":"Kleeff","year":"2007","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.04.009_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2016.10.023","article-title":"Radical surgery of oligometastatic pancreatic cancer","volume":"43","author":"Hackert","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.surg.2016.02.019","article-title":"Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis","volume":"160","author":"Tachezy","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.suc.2024.04.009_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/jhbp.1303","article-title":"Oncologic resection of pancreatic cancer with isolated liver metastasis: Favorable outcomes in select patients","author":"Nagai","year":"2023","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13304-020-00710-z","article-title":"A\u00a0systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy","volume":"72","author":"Crippa","year":"2020","journal-title":"Updates Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s12885-018-4679-9","article-title":"Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior","volume":"18","author":"Sahin","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.suc.2024.04.009_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5858\/133.3.413","article-title":"The pathology and genetics of metastatic pancreatic cancer","volume":"133","author":"Yachida","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.suc.2024.04.009_bib44","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jhbp.1127","article-title":"Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis","volume":"29","author":"Homma","year":"2022","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib45","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1038\/s41598-020-61487-0","article-title":"Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1245\/s10434-008-0295-2","article-title":"Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma","volume":"16","author":"Katz","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2024.04.009_bib47","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s11605-011-1605-8","article-title":"Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival","volume":"15","author":"Arnaoutakis","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.suc.2024.04.009_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2018.10.008","article-title":"Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis","volume":"106","author":"Mackay","year":"2019","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib49","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1245\/s10434-020-08316-w","article-title":"The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms","volume":"27","author":"Group","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib50","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1245\/s10434-020-08315-x","article-title":"The Chicago consensus on peritoneal surface malignancies: management of colorectal metastases","volume":"27","author":"Group","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib51","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1245\/s10434-020-08320-0","article-title":"The Chicago consensus on peritoneal surface malignancies: management of gastric metastases","volume":"27","author":"Group","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2024.04.009_bib52","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ejso.2022.05.030","article-title":"Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: A systematic review and meta-analysis","volume":"48","author":"Frassini","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2024.04.009_bib53","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.21037\/jgo-20-243","article-title":"Conversion surgery in patients with pancreatic cancer and peritoneal metastasis","volume":"12","author":"Yamada","year":"2021","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"13","key":"10.1016\/j.suc.2024.04.009_bib54","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/bjs.11792","article-title":"Phase I\/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis","volume":"107","author":"Yamada","year":"2020","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib55","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.3747\/co.26.4903","article-title":"FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study","volume":"26","author":"Bonnet","year":"2019","journal-title":"Curr Oncol"},{"issue":"12","key":"10.1016\/j.suc.2024.04.009_bib56","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1245\/s10434-023-14138-3","article-title":"Oncologic outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for highly selected patients with metastatic pancreatic ductal adenocarcinoma","volume":"30","author":"Gudmundsdottir","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znad419","article-title":"Surgery for oligometastatic pancreatic cancer: next frontier?","volume":"111","author":"Larsson","year":"2024","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.suc.2024.04.009_bib58","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jamasurg.2019.3337","article-title":"Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial","volume":"154","author":"Jones","year":"2019","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.suc.2024.04.009_bib59","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1245\/s10434-018-6558-7","article-title":"Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"25","author":"Groot","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib60","first-page":"1715","article-title":"Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data","volume":"12","author":"Wu","year":"2021","journal-title":"J\u00a0Cancer"},{"issue":"5","key":"10.1016\/j.suc.2024.04.009_bib61","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s10147-022-02131-x","article-title":"Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer","volume":"27","author":"Sasaki","year":"2022","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.suc.2024.04.009_bib62","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pan.2021.01.014","article-title":"The impact of different metastatic patterns on survival in patients with pancreatic cancer","volume":"21","author":"He","year":"2021","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040497","article-title":"Head and Body\/Tail Pancreatic Carcinomas Are Not the Same Tumors","volume":"11","author":"Birnbaum","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","article-title":"Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer","volume":"261","author":"Ferrone","year":"2015","journal-title":"Ann Surg"},{"issue":"23","key":"10.1016\/j.suc.2024.04.009_bib65","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1002\/cncr.27636","article-title":"Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators","volume":"118","author":"Katz","year":"2012","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.suc.2024.04.009_bib66","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.6004\/jnccn.2022.7041","article-title":"FDG-PET predicts neoadjuvant therapy response and survival in borderline resectable\/locally advanced pancreatic adenocarcinoma","volume":"20","author":"Abdelrahman","year":"2022","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.suc.2024.04.009_bib67","doi-asserted-by":"crossref","first-page":"101909","DOI":"10.1016\/j.suronc.2023.101909","article-title":"Added value of digital FDG-PET\/CT in disease staging and restaging in patients with resectable or borderline resectable pancreatic cancer","volume":"47","author":"de Jong","year":"2023","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2024.04.009_bib68","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib69","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/SLA.0000000000003049","article-title":"Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer","volume":"271","author":"Tsai","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2024.04.009_bib70","doi-asserted-by":"crossref","first-page":"754687","DOI":"10.3389\/fonc.2021.754687","article-title":"The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma","volume":"11","author":"George","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.suc.2024.04.009_bib71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jhbp.1184","article-title":"Outcomes of pancreatic cancer with liver oligometastasis","volume":"30","author":"Takeda","year":"2023","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.suc.2024.04.009_bib73","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ags3.12317","article-title":"Application of liquid biopsy for surgical management of pancreatic cancer","volume":"4","author":"Nagai","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-023-01870-3","article-title":"Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation","volume":"22","author":"Wang","year":"2023","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/bjc.2016.175","article-title":"Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer","volume":"115","author":"Hadano","year":"2016","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1158\/1078-0432.CCR-16-0806","article-title":"Plasma circulating tumor DNA in pancreatic cancer patients is a prognostic marker","volume":"23","author":"Pietrasz","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib77","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/1535-7163.MCT-17-1298","article-title":"Monitoring tumor burden in response to FOLFIRINOX chemotherapy via profiling circulating cell-free DNA in pancreatic cancer","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer Therapeut"},{"issue":"16","key":"10.1016\/j.suc.2024.04.009_bib78","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1158\/1078-0432.CCR-19-0197","article-title":"Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer","volume":"25","author":"Groot","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.suc.2024.04.009_bib79","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s13277-013-1327-5","article-title":"Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis","volume":"35","author":"Han","year":"2014","journal-title":"Tumour Biol"},{"issue":"12","key":"10.1016\/j.suc.2024.04.009_bib80","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/bjc.2016.121","article-title":"Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer","volume":"114","author":"Ankeny","year":"2016","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040622","article-title":"Detection of circulating tumor cells using negative enrichment immunofluorescence and an in\u00a0situ hybridization system in pancreatic cancer","volume":"18","author":"Xu","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.suc.2024.04.009_bib82","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41416-021-01350-9","article-title":"Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer","volume":"124","author":"Semaan","year":"2021","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.suc.2024.04.009_bib83","article-title":"Current State of \"Omics\" Biomarkers in Pancreatic Cancer","volume":"11","author":"Turanli","year":"2021","journal-title":"J\u00a0Personalized Med"},{"issue":"6","key":"10.1016\/j.suc.2024.04.009_bib84","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-17-2994","article-title":"Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS Trial","volume":"24","author":"Aung","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.suc.2024.04.009_bib85","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2022.07.019","article-title":"Ablative radiation therapy in oligometastatic pancreatic cancer to delay polyprogression, limit chemotherapy, and improve outcomes","volume":"114","author":"Elamir","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib86","first-page":"88","article-title":"Survival of patients with oligometastatic pancreatic ductal adenocarcinoma treated with combined modality treatment including surgical resection: a pilot study","volume":"4","author":"Kandel","year":"2018","journal-title":"J\u00a0Pancreat Cancer"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib87","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/02656736.2021.1905189","article-title":"Histotripsy: the first noninvasive, non-ionizing, non-thermal ablation technique based on ultrasound","volume":"38","author":"Xu","year":"2021","journal-title":"Int J Hyperther"},{"issue":"2","key":"10.1016\/j.suc.2024.04.009_bib88","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00270-022-03309-6","article-title":"A\u00a0multi-centre, single arm, non-randomized, prospective european trial to evaluate the safety and efficacy of the histosonics system in the treatment of primary and metastatic liver cancers (#HOPE4LIVER)","volume":"46","author":"Wah","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"10.1016\/j.suc.2024.04.009_bib89","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1109\/TUFFC.2021.3100267","article-title":"Liver histotripsy mediated abscopal effect-case report","volume":"68","author":"Vidal-Jove","year":"2021","journal-title":"IEEE Trans Ultrason Ferroelectrics Freq Control"},{"issue":"1","key":"10.1016\/j.suc.2024.04.009_bib90","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","article-title":"Systematic review of case reports on the abscopal effect","volume":"40","author":"Abuodeh","year":"2016","journal-title":"Curr Probl Cancer"},{"issue":"5","key":"10.1016\/j.suc.2024.04.009_bib91","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.suc.2024.04.009_bib92","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.4_suppl.TPS638","article-title":"GATA6 Expression as a predictor of response to perioperative chemotherapy in resectable pancreatic adenocarcinoma\" A multicenter Canadian phase II study (NeoPancONE)","volume":"40","author":"Kelly","year":"2022","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610924000641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610924000641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T08:11:25Z","timestamp":1725437485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610924000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0039610924000641"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2024.04.009","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Surgery in \u201cOligometastatic\u201d Pancreas Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2024.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}